# Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells

> **NCT07344324** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 15 (estimated)

## Conditions studied

- Diabete Type 2
- Insulin Resistant Diabetes (Mellitus)
- Obesity

## Interventions

- **PROCEDURE:** endoscopic duodenal injection of ADMSCs

## Key facts

- **NCT ID:** NCT07344324
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-02
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07344324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07344324, "Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07344324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*